Search

everythinglearnresearchcommunity

for

Search:↓

Arachidonic acid helps hair grow by increasing growth factors and improving follicle health.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Setipiprant did not significantly improve hair growth in men with hair loss.

Targeting and modifying the stem cell niche can improve regenerative therapies.

Genetic factors could lead to personalized treatments for hair loss.

Higher levels of the DP2 receptor may lead to hair loss.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

No genetic link between prostaglandins and hair loss found.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Prostanoids, like prostaglandins and thromboxane A2, can both enhance and inhibit hair growth, and understanding their effects could help treat hair disorders.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.